DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20203340

Evaluation of urea and creatinine levels in vaginal wash fluid for the diagnosis of premature rupture of membranes

Abha Sharma, Richa Sharma, Tannavi Agarwal

Abstract


Background: Evaluation of urea and creatinine levels in vaginal wash fluid for the diagnosis of premature rupture of membranes.

Methods: The study was conducted on150 pregnant patients, 50 in each group. Confirmed PROM and unconfirmed PROM. Per speculum examination was done to look for pooling, pH tested using the Pehanon paper and vaginal wash fluid was collected. Vaginal wash fluid urea and creatinine levels were tested by a kit based on spectrophotometry.

Results: The mean urea levels were 26.35 mg/dl in the study Group 1 and 3.12 mg/dl in the control group. ROC curve was plotted and the cut off value of vaginal wash fluid urea was found to be 8.55 mg/dl. The vaginal wash fluid urea levels of >8.55 mg/dl detected PROM with a sensitivity, specificity, negative and positive predictive value of 100%. The mean creatinine levels were 0.62 mg/dl in study Group 1 and 0.20 mg/dl in the control group. ROC curve was plotted and the cut off value of vaginal wash fluid creatinine was found to be 0.405 mg/dl. Vaginal wash fluid creatinine levels detected PROM with a sensitivity of 76% and specificity of 100%. The negative predictive value and positive predictive values were 80.4% and 100%.

Conclusions: Urea can be used as a definite marker of PROM and creatinine can be used as a supportive marker.


Keywords


Creatinine levels, Definite marker, Premature rupture of membranes, Urea level

Full Text:

PDF

References


ACOG Committee on Practice Bulletins-Obstetrics, authors. Clinical management guidelines for obstetrician-gynecologists. (ACOG Practice Bulletin No. 80: premature rupture of membranes). Obstet Gynecol. 2007;109:1007-1019.

Gallot D, Guibourdenche J, Sapin V, Goffinet F, Doret M, Langer B, et al. Which biological test to confirm rupture of membranes? J Gynecol Obstet Biol Reprod. 2012;41:115-21.

Méhats C, Schmitz T, Marcellin L, Breuiller-Fouché M. Biochemistry of fetal membranes rupture. Gynecol Obstet Fertil. 2011;39:365-9.

Martinuzzi K, Mariona F. Comment and reply on: The clinical significance of a positive AmniSure test in women with term labor with intact membranes. J Matern Fetal Neonatal Med. 2011;24:654.

Erdemoglu E, Mungan T. Significance of detecting insulin‐like growth factor binding protein‐1 in cervicovaginal secretions: comparison with nitrazine test and amniotic fluid volume assessment. Acta Obstet Gynecol Scand. 2004;83:622-6.

Caughey AB, Robinson JN, Norwitz ER. Contemporary diagnosis and management of preterm premature rupture of membranes. Rev Obstet Gynecol. 2008;1(1):11-22.

Kafali H, Oksuzler C. Vaginal fluid urea and creatinine in diagnosis of premature rupture of membranes. Arch Gynecol Obstet. 2007;275:157-60.

Gurbuz A, Karateke A, Kabaca C. Vaginal fluid creatinine in premature rupture of membranes. Int J Gynecol Obstet. 2004;85(3):270-1.

Robson MS, Turner MJ, Stronge JM, O’Herlihy CO. Is amniotic fluid quantitation of value in the diagnosis and conservative management of prelabour membrane rupture at term? Br J Obstet Gynaecol. 1990;97:324-8.

Oliveira FR, Barros EG, Magalhães JA. Biochemical profile of amniotic fluid for the assessment of fetal and renal development. Braz J Med Biol Res. 2002;35(2):215-2.

Deshpande TV, Harding PG, Jaco NT. Estimation of gestational age from study of amniotic fluid and clinical assessment. Can Med Assoc J. 1977;117(8):886-90.